| Clinical Guidelines |
0 |
0.99 |
| Biologic Therapy |
0 |
0.49 |
| Child |
0 |
0.45 |
| Myositis |
0 |
1 |
| Fractures |
0 |
0.37 |
| Cancer |
0 |
0.34 |
| Inclusion Body Myositis |
0 |
0.29 |
| Antineoplastic Drug |
0 |
0.28 |
| Preventive Screening |
0 |
0.23 |
| Dysphagia |
0 |
0.11 |
| Myopathy |
0 |
0.11 |
| CT Scan |
0 |
0.09 |
| Skeletal Myoblasts |
0 |
0.09 |
| Endoscopy |
0 |
0.07 |
| Glucocorticoid |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.07 |
| Muscle |
0 |
0.07 |
| Positron Emission Tomography |
0 |
0.06 |
| Interstitial Lung Disease |
0 |
0.05 |
| Exercise |
0 |
0.04 |
| Geriatrics |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Intravenous |
0 |
0.04 |
| Lung |
0 |
0.04 |
| Meta-Analysis |
0 |
0.04 |
| Monoclonal Antibody |
0 |
0.04 |
| Neuromuscular Diseases |
0 |
0.04 |
| Refractory |
0 |
0.04 |
| Scan |
0 |
0.04 |
| Skeletal |
0 |
0.04 |